Literature DB >> 4629128

Serum and nasal secretion immune response in meningococcal disease.

R P Wenzel, J R Mitzel, J A Davies, W E Beam.   

Abstract

Nasal antibodies to meningococcal organisms were demonstrable by the indirect fluorescent-antibody test in three patients. Serogroup cross-reactions were usual.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4629128      PMCID： PMC422415          DOI： 10.1128/iai.5.4.627-629.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  8 in total

1.  Prevention of meningococcal infections.

Authors:  E Sanders; W B Deal
Journal:  J Infect Dis       Date:  1970-04       Impact factor: 5.226

2.  The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population.

Authors:  W E Beam; N R Newberg; L F Devine; W E Pierce; J A Davies
Journal:  J Infect Dis       Date:  1971-07       Impact factor: 5.226

3.  Prevention of meningococcal disease by group C polysaccharide vaccine.

Authors:  M S Artenstein; R Gold; J G Zimmerly; F A Wyle; H Schneider; C Harkins
Journal:  N Engl J Med       Date:  1970-02-19       Impact factor: 91.245

4.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

5.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

6.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

7.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

8.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
  8 in total
  1 in total

1.  Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice.

Authors:  N B Saunders; D R Shoemaker; B L Brandt; E E Moran; T Larsen; W D Zollinger
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.